| |
| |
|
| Insider
Information: |
Henneman John B III |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
8 |
|
| Direct
Shares |
263,813 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,781,284 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
263,813 |
|
|
| Total
Value |
$3,781,284 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
1
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
-1.0
|
-1.0
|
| Percentage
Gain/Loss : |
 -27.9%
|
-30.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Integra Lifesciences Holdings Corp |
IART |
CorpVP, CAO |
2014-08-25 |
34,159 |
2003-07-14 |
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Chief Administrative O... |
2018-10-01 |
55,052 |
2014-10-01 |
0 |
Premium* |
|
|
Seaspine Holdings Corp |
SPNE |
Director |
2023-01-05 |
0 |
2016-06-07 |
0 |
Premium* |
|
|
R1 RCM Inc |
ACHI |
Director |
2022-06-21 |
0 |
2016-08-16 |
0 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
Director |
2024-03-13 |
8,139 |
2019-10-07 |
0 |
Premium* |
|
|
Anika Therapeutics Inc |
ANIK |
Director |
2023-06-14 |
29,936 |
2020-09-03 |
0 |
Premium* |
|
|
R1 Rcm Inc |
RCM |
Director |
2024-05-23 |
87,765 |
2022-06-21 |
0 |
Premium* |
|
|
Orthofix International N.V. |
OFIX |
Director |
2023-01-05 |
48,762 |
2023-01-05 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
168 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 6 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2016-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
16,201 |
62,491 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2016-01-05 |
4 |
S |
$35.74 |
$6,255 |
D/D |
(175) |
62,316 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2016-06-07 |
4 |
A |
$0.00 |
$0 |
D/D |
10,010 |
18,903 |
0 |
- |
|
| ACHI |
R1 RCM Inc |
Director |
– • – |
2016-08-16 |
4 |
B |
$1.77 |
$90,098 |
D/D |
50,000 |
50,000 |
2.39 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2016-10-01 |
4 |
D |
$15.02 |
$41,891 |
D/D |
(2,789) |
60,099 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2017-01-03 |
4 |
D |
$10.28 |
$1,686 |
D/D |
(164) |
59,935 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2017-01-04 |
4 |
D |
$11.04 |
$14,606 |
D/D |
(1,323) |
58,612 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2017-06-14 |
4 |
A |
$0.00 |
$0 |
D/D |
15,121 |
34,024 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2017-10-01 |
4 |
D |
$10.18 |
$28,392 |
D/D |
(2,789) |
56,544 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2018-01-02 |
4 |
D |
$8.47 |
$1,389 |
D/D |
(164) |
58,859 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
EVP, Chief Financial Officer |
• – – |
2018-01-04 |
4 |
D |
$10.06 |
$13,309 |
D/D |
(1,323) |
57,536 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2018-05-30 |
4 |
A |
$0.00 |
$0 |
D/D |
13,286 |
47,310 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2018-06-13 |
4 |
OE |
$12.44 |
$216,431 |
D/D |
17,398 |
64,708 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2018-08-27 |
4 |
S |
$14.72 |
$67,182 |
D/D |
(4,564) |
60,144 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2018-08-28 |
4 |
S |
$14.65 |
$29,725 |
D/D |
(2,029) |
58,115 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2018-08-29 |
4 |
S |
$14.65 |
$49,913 |
D/D |
(3,407) |
54,708 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Administrative Officer |
• – – |
2018-10-01 |
4 |
D |
$2.28 |
$5,664 |
D/D |
(2,484) |
55,052 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2019-05-29 |
4 |
A |
$0.00 |
$0 |
D/D |
7,262 |
61,970 |
0 |
- |
|
| APRE |
Aprea Therapeutics, Inc. |
|
• • – |
2019-10-07 |
4 |
B |
$15.00 |
$75,000 |
D/D |
5,000 |
5,000 |
0.01 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2020-06-03 |
4 |
A |
$0.00 |
$0 |
D/D |
8,488 |
70,458 |
0 |
- |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2020-08-05 |
4 |
AS |
$15.00 |
$150,000 |
D/D |
(10,000) |
60,458 |
0 |
% |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2020-09-03 |
4 |
A |
$0.00 |
$0 |
D/D |
9,310 |
9,310 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2021-05-18 |
4 |
B |
$42.86 |
$85,720 |
D/D |
2,000 |
11,310 |
2.39 |
% |
|
| SPNE |
Seaspine Holdings Corp |
Director |
– • – |
2021-06-02 |
4 |
A |
$0.00 |
$0 |
D/D |
6,253 |
66,711 |
0 |
- |
|
| ANIK |
Anika Therapeutics Inc |
Director |
– • – |
2021-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
4,172 |
15,482 |
0 |
- |
|
168 Records found
|
|
Page 6 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
